In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea
Open Access
- 1 January 2008
- journal article
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 23 (1), 49-52
- https://doi.org/10.3346/jkms.2008.23.1.49
Abstract
Mycobacterium abscessus is the second most common etiology of pulmonary disease caused by nontuberculous mycobacteria in Korea. Although antimicrobial susceptibility tests are important for appropriate patient management in M. abscessus lung disease, the tests have never been investigated in Korea. Seventy-four isolates of M. abscessus recovered from patient respiratory samples were tested against eight antimicrobial agents following the guidelines set forth by the National Committee for Clinical Laboratory Standards. Of the parenteral antibiotics, amikacin (99%, 73/74) and cefoxitin (99%, 73/74) were active against most isolates. Imipenem (55%, 36/66) and tobramycin (36%, 27/74) had activity against moderate number of isolates. Of the oral antibiotics, clarithromycin (91%, 67/74) was active against the majority of isolates. Moxifloxacin (73%, 54/74) and ciprofloxacin (57%, 42/74) had activity against a moderate number of isolates. Doxycycline was the least active, inhibiting only 7% (5/74) of isolates. In conclusion, the variations in susceptibility within M. abscessus isolates to currently available antimicrobials suggest that the antimicrobial susceptibilities of any clinically significant M. abscessus isolate be needed individually.Keywords
This publication has 15 references indexed in Scilit:
- Identification of an Emerging Pathogen, Mycobacterium massiliense , by rpoB Sequencing of Clinical Isolates Collected in the United StatesJournal of Clinical Microbiology, 2007
- Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in KoreaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Mycobacterium kansasii Pulmonary Diseases in KoreaJournal of Korean Medical Science, 2005
- Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases: A Korean PerspectiveJournal of Korean Medical Science, 2005
- Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial Agents and Chemotherapy, 1992
- Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acidAntimicrobial Agents and Chemotherapy, 1991
- Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapyAntimicrobial Agents and Chemotherapy, 1990
- Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 1985
- Treatment of Nonpulmonary Infections Due to Mycobacterium fortuitum and Mycobacterium chelonei on the Basis of in Vitro SusceptibilitiesThe Journal of Infectious Diseases, 1985
- Spectrum of Disease Due to Rapidly Growing MycobacteriaClinical Infectious Diseases, 1983